Isaac Kohlberg
Direktor/Vorstandsmitglied bei ACACIA RESEARCH CORPORATION
Vermögen: 299 038 $ am 30.04.2024
Profil
Isaac Theodore Kohlberg is currently serving as an Independent Director at Acacia Research Corp., a Director at TTFactor Società Benefit Srl, a Director at Eclosion2 & Cie Scpc, and a Non-Executive Director at Arix Bioscience.
He also holds the position of Chief Technology Development Officer at Harvard University and Sr. Associate Provost & Chief Tech.
Dev't Officer at the Office of Technology Development.
In his former roles, Kohlberg served as the Chief Executive Officer at Ramot at Tel Aviv University Ltd., Tel Aviv University Economic Corp.
Ltd., and Yeda Research & Development Co. Ltd.
He was also the Chief Executive Officer at Tel-Aviv University from 2001 to 2005.
Additionally, he served as a Director at Anchiano Therapeutics Ltd., Elicio Therapeutics, Inc., and eXIthera Pharmaceuticals, Inc. He held the position of Director at Clal Biotechnology Industries Ltd.
from 2015 to 2020 and is currently serving as a Non-Executive Director at Arix Bioscience Plc until 2024.
Kohlberg was a Professor & Vice Provost at New York University from 1989 to 2000 and also worked as a Strategic Advisor at Access BridgeGap Ventures.
He held the position of VP-Industrial Liaison, Head-Science & Technology at New York University Medical Center.
Kohlberg completed his MBA from INSEAD in 1981 and graduated from Tel-Aviv University in 1979.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.04.2024 | 61 153 ( 0,06% ) | 299 038 $ | 30.04.2024 |
Aktive Positionen von Isaac Kohlberg
| Unternehmen | Position | Beginn |
|---|---|---|
| ACACIA RESEARCH CORPORATION | Direktor/Vorstandsmitglied | 06.05.2019 |
| Eclosion2 & Cie Scpc | Direktor/Vorstandsmitglied | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
TTFactor Società Benefit Srl
 TTFactor Società Benefit Srl Medical/Nursing ServicesHealth Services TTfactor SRL develops oncology research, technology advancement and intellectual property transfer programs. It operates as a technology transfer and market connection company focused on the advancement of scientific results through technology licensing, sponsored research, clinical trials, drug discovery, and molecular medicine programs. The company was founded by Daniela Bellomo in 2010 and is headquartered in Milan, Italy. | Direktor/Vorstandsmitglied | - |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Direktor/Vorstandsmitglied | 29.04.2021 |
Ehemalige bekannte Positionen von Isaac Kohlberg
| Unternehmen | Position | Ende |
|---|---|---|
| ARIX BIOSCIENCE PLC | Direktor/Vorstandsmitglied | 22.01.2024 |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Direktor/Vorstandsmitglied | 22.05.2020 |
Access BridgeGap Ventures
 Access BridgeGap Ventures Investment ManagersFinance Founded in 2011, Access BridgeGap Ventures is a venture capital firm located in Cambridge, Massachusetts. The firm is the life sciences venture capital investment arm of Access Industries, Inc. | Corporate Officer/Principal | 10.10.2013 |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Isaac Kohlberg
| INSEAD | Masters Business Admin |
| Tel-Aviv University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| ALLON THERAPEUTICS INC. | Health Technology |
| ACACIA RESEARCH CORPORATION | Commercial Services |
| ARIX BIOSCIENCE PLC | Finance |
| Private Unternehmen | 12 |
|---|---|
Ramot at Tel Aviv University Ltd.
 Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel. | Commercial Services |
| Tel Aviv University Economic Corp. Ltd. | |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Health Technology |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Yeda Research & Development Co. Ltd.
 Yeda Research & Development Co. Ltd. Investment ManagersFinance Yeda Research & Development Co. Ltd. engages in development of natural science and services. It covers broad of spectrum including: biotechnology, pharmaceuticals and diagnostics, bioinformatics, proteomics, biomatics and system biology, medical devices, renewable energy, bio fuels, clean technology and environmental sciences, agricultural and plants genetics, chemistry and nanotechnology, physics and electro-optics, mathematics and computer science. The company is headquartered in Rehovot, Israel. | Finance |
Access BridgeGap Ventures
Access BridgeGap Ventures Investment ManagersFinance Founded in 2011, Access BridgeGap Ventures is a venture capital firm located in Cambridge, Massachusetts. The firm is the life sciences venture capital investment arm of Access Industries, Inc. | Finance |
TTFactor Società Benefit Srl
TTFactor Società Benefit Srl Medical/Nursing ServicesHealth Services TTfactor SRL develops oncology research, technology advancement and intellectual property transfer programs. It operates as a technology transfer and market connection company focused on the advancement of scientific results through technology licensing, sponsored research, clinical trials, drug discovery, and molecular medicine programs. The company was founded by Daniela Bellomo in 2010 and is headquartered in Milan, Italy. | Health Services |
| Eclosion2 & Cie Scpc | |
New York University Medical Center
 New York University Medical Center Other Consumer ServicesConsumer Services Part of New York University, New York University Medical Center is a healthcare provider that offers personalized treatment for reproductive and sexual health conditions in men and women. The company is based in New York and provides emergency and urgent care at various locations, as well as Virtual Urgent Care. NYU Langone's Community Health Needs Assessment and Service Plan aims to support behavior change and disease prevention at the neighborhood level. The American company was founded by J. Ira Harris. | Consumer Services |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Finance |
